Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir)

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has been awarded the prestigious 2025 Prix Galien USA Award for Best ...

Gilead Sciences (GILD) Profit Margin Surge Reinforces Bullish Narratives on Operational Turnaround

Gilead Sciences (GILD) delivered a net profit margin of 27.9%, a sharp turnaround from just 0.4% a year ago, with earnings ...
sharewise

GILD Q3 Earnings and Sales Beat Estimates, HIV and Livdelzi Sales Grow

Gilead Sciences, Inc. GILD posted better-than-expected third-quarter 2025 results and lifted the lower end of its product ...
Le Lézard

Nootropics Depot Advances Supplement Science with Unmatched Research and Development

Nootropics Depot is redefining the landscape of dietary supplements through its uncompromising research and development (R&D) initiatives. By integrating advanced laboratory technology, rigorous ...
Le Lézard

Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition

Pfizer Inc. today announced the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR ...